Type 2 diabetes mellitus in children and adolescents: Where do we stand with drug treatment and behavioral management?

Current Diabetes Reports

Volumn 8, Issue 5, 2008, Pages 383-388

  Nader, Nicole S ^b   Kumar, Seema ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; GLIMEPIRIDE; INSULIN; INSULIN GLARGINE; METFORMIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; SULFONYLUREA; ANTIDIABETIC AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADOLESCENT; AGE DISTRIBUTION; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; BODY MASS; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIARRHEA; DIET THERAPY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ETHNICITY; FAMILY HISTORY; FLATULENCE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART DISEASE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INCIDENCE; INSULIN SENSITIVITY; LACTIC ACIDOSIS; LIFESTYLE MODIFICATION; MATERNAL DIABETES MELLITUS; MONOTHERAPY; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PREVALENCE; PUBERTY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SKIN MANIFESTATION; WEIGHT GAIN; WEIGHT REDUCTION; ARTICLE; HEALTH BEHAVIOR;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 2; HEALTH BEHAVIOR; HUMANS; HYPOGLYCEMIC AGENTS; OBESITY; RISK FACTORS;

EID: 58149376449     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0066-2     Document Type: Review

References (36)

1. Type 2 diabetes in children and adolescents. American Diabetes Association [no authors listed]. Diabetes Care 2000, 23:381-389.
2. Kaufman FR: Type 2 diabetes mellitus in chAldren and youth: a new epidemic. J Pediatr Endocrinol Metab 2002, 15(Suppl 2):737-744.
3. Dabelea D, Bell RA, D'Agostino RB Jr, et al.: Incidence of diabetes in youth in the United States. JAMA 2007, 297:2716-2724.
4. Cockram CS: The epidemiology of diabetes mellitus in the Asia-Pacific Region. Hong Kong Med J 2000, 6:43-52.
5. Pinhas-Hamiel O, Zeitler P: Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes 2007, 8(Suppl 9):16-27.
6. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al.: Type 2 diabetes among North American children and adolescents: An epidemiological review and public health perspective. J Pediatr 2000, 136:664-672.
7. Rosenbloom A, Joe J, Young R, Winter W: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999, 22:345-354.
8. Palmert MR, Gordon CM, Kartashov AI, et al.: Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metabol 2002, 87:1017-1023.
9. Wei JN, Sung FC, Li CY, et al.: Low birth weight and high birthweight infants are both at an increased risk to have type 2 diabetes among schoolchildren in Taiwan. Diabetes Care 2003, 26:343-348.
10. Pettitt DJ, Nelson RG, Saad MF, et al.: Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993, 18:611-617.
11. Nathan BM: The increase of type 2 diabetes mellitus in children. Minn Med 2007, 90:39-43.
12. Pinhas-Hamiel O, Dolan LM, Zeitler P: Diabetic ketoacidosis among obese African-American adolescents with NIDDM. Diabetes Care 1997, 20:484-486.
13. Fourtner SH, Weinzimer SA, Levitt Katz LE: Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes. Pediatr Diabetes 2005, 6:129-135.
14. Gahagan S, Silverstein J: Prevention and treatment of type 2 diabetes mellitus in children with special emphasis on American Indian and Alaska native children. Pediatrics 2003, 112:e328.
15. DeFronzo RAB The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988, 37:667-687.
16. Alberti G, Zimmet P, ShaT J, et al.: Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 2004, 27:1798-1811.
17. Bradshaw B: The role of the family in managing therapy in minority children with type 2 diabetes mellitus. Pediatr Diabetes 2005, 15:547-551.
18. Epstein LH, Meyers MD, Raynor HA, Saelens BE: Treatment of pediatric obesity. Pediatrics 1998, 101 (3 Pt 2):554-570.
19. Ebbeling CB, Sinclair KB, Hangen JP, Ludwig DJ: A reduced glycemic load diet in the treatment of adolescent obesity. Pediatr Adolesc Med 2003, 157:773-779.
20. Sondike SB: Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr 2003, 142:253-258.
21. Willi S, Martin K, Datko F, Brant B: Treatment of type 2 diabetes in childhood using a very-low-calorie diet. Diabetes Care 2004, 27:348-353.
22. Giannini C, de Giorgis T, Mohn A, Chiarelli F: Role of physical exercise in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metabol 2007, 20:173-184.
23. Shabi GQ, Cruz ML, Ball GD, et al.: Effects of resistance training on insulin sensitivity in overweight Latino adolescent males. Med Sci Sports Exerc 2006, 38:1208-1215.
24. Watts K, Jones TW, Davis EA, Green D: Exercise training in obese children and adolescents: Current concepts. Sports Med 2005, 35:375-392.
25. Jones KL, Arslanian S, Peterokova VA, et al.: Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002, 25:89-94.
26. Salpeter SR, Greyber E, Pasternak GA, et al.: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 2003, 163:2594-2602.
27. The TODAY study group: Treatment options for type 2 diabetes in adolescents and youth: A study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007, 8:74-87.
28. Nissen SE, Wolski K: Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457-2471.
29. Meier C, Kraenzlin ME, Bodmer M, et al.: Use of thiazolidinediones and fracture risk. Arch Intern Med 2008, 168:820-825.
30. Gottschalk M, Danne T, Vlajnic A, Cara JF: Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes. Diabetes Care 2007, 30:790-794.
31. Gungor N, Hannon T, Tibman I, et al.: Type 2 diabetes in youth: the complete picture to date. Pediatr Clin North Am 2005, 52:1579-1609.
32. Silverstein JH, Rosenbloom AL: Treatment of type 2 diabetes in children and adolescents. J Pediatr Endocrinol Metab 2000, 13:1403-1409.
33. Pinhas-Hamiel O, Zeitler P: Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007, 369:1823-1831.
34. Petitti DB, Imperatore G, Palla SL, et al.: Serum lipids and glucose control: The SEARCH for diabetes in youth study. Arch Pediatr Adolesc Med 2007, 161:159-165.
35. McCrindle BW, Urbina EM, Dennison BA, et al.: Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association atherosclerosis hypertension, and obesity in youth Committee, council of cardiovascular disease in the young, with the council of cardiovascular nursing. Circulation 2007, 115:1948-1967.
36. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2006, 29(Suppl 1):s4-s42. (Published erratum appears in Diabetes Care 2006, 29:1192.)